tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Amsellem, 417 are a BUY (74.07%), 134 are a HOLD (23.8%), 12 are a SELL (2.13%).
Analyst David Amsellem, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 55.57% that have a potential upside of 28.16% achieved within 248 days.
David Amsellem’s has documented 1,112 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Consumer Defensive, Financial Services sectors.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 17-Sep-2026.
Analyst best performing recommendations are on RVNC (REVANCE THE).
The best stock recommendation documented was for RVNC (REVANCE THE) at 8/9/2024. The price target of $6 was fulfilled within 3 days with a profit of $2.47 (69.97%) receiving and performance score of 233.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Nov-2017
$8.5
$0.28 (3.41%)
4 years 10 months 13 days ago
(18-Nov-2021)
0/3 (0%)
$0.33 (4.04%)
Buy Since 12-Jan-2016
$8
$-0.22 (-2.68%)
$7
4 years 11 months 18 days ago
(13-Oct-2021)
4/5 (80%)
$-0.07 (-0.87%)
95
Buy Since 17-Aug-2017
$14
4 years 11 months 18 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold Since 13-Oct-2021
$8
$-0.22 (-2.68%)
$10
4 years 11 months 18 days ago
(13-Oct-2021)
1/7 (14.29%)
$-0.07 (-0.87%)
6
Buy
$6
$-2.22 (-27.01%)
$20
4 years 11 months 19 days ago
(12-Oct-2021)
0/2 (0%)
$3.2 (23.94%)
Which stock is David Amsellem most bullish on?
Which stock is David Amsellem most reserved on?
What Year was the first public recommendation made by David Amsellem?
